ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
FibroBiologics
1.76
+0.0500
2.92%
盘前:
1.80
0.0400
+2.27%
07:48 EDT
成交量:
13.83万
成交额:
23.94万
市值:
1,171.84万
市盈率:
-0.37
高:
1.80
开:
1.73
低:
1.62
收:
1.71
52周最高:
12.40
52周最低:
0.6201
股本:
665.82万
流通股本:
584.31万
量比:
0.24
换手率:
2.37%
股息:
- -
股息率:
- -
每股收益(TTM):
-4.7656
每股收益(LYR):
-8.3501
净资产收益率:
-660.08%
总资产收益率:
-95.77%
市净率:
2.53
市盈率(LYR):
-0.21
数据加载中...
总览
公司
新闻
公告
FibroBiologics宣布获得美国新专利:利用成纤维细胞条件培养基治疗椎间盘退行性疾病
美股速递
·
09/01
Fibrobiologics发布第三批Cywc628药物产品,用于1/2期糖尿病足溃疡临床试验
美股速递
·
08/27
Fibrobiologics宣布:大麻二酚辅助治疗椎间盘退行性疾病的澳大利亚专利已获授权
美股速递
·
08/20
FibroBiologics 因一项与胰岛素分泌细胞移植技术相关的专利而获益
路透中文
·
08/11
FibroBiologics获美国专利:成纤维细胞可增强移植胰岛细胞存活与功能
美股速递
·
08/11
FibroBiologics 2026年第二季度财报:净亏损410万美元,CYWC628进入临床
TradingKey中文
·
08/05
FibroBiologics发布2026年第二季度财报:主导伤口护理候选药物临床试验稳步推进
美股速递
·
08/01
FibroBiologics提交SEC文件:注册出售股东至多1253万股普通股转售
美股速递
·
07/10
FibroBiologics完成第三批Cywc628药物生产,用于糖尿病足溃疡1/2期临床试验
美股速递
·
07/07
FibroBiologics宣布完成最高900万美元按市价定价的私募配售
美股速递
·
06/30
FibroBiologics获美国专利授权通知,覆盖用于伤口愈合的局部成纤维细胞球体疗法
美股速递
·
06/22
FibroBiologics推进针对糖尿病足溃疡的Ciwc628药物1/2期临床试验患者给药
美股速递
·
06/16
FibroBiologics宣布首批患者接受Cywc628治疗糖尿病足溃疡的1/2期临床试验给药
美股速递
·
06/03
新闻稿:FibroBiologics 在皮肤研究学会2026年会上公布临床前数据,展示其银屑病疗法持久的免疫调节作用
投资观察
·
05/22
FibroBiologics启动1/2期临床试验 评估CYWc628对糖尿病足溃疡患者的安全性、耐受性及疗效
美股速递
·
05/04
FibroBiologics宣布Cywc628药物产品完成生产 将用于糖尿病足溃疡1/2期临床试验
美股速递
·
05/04
FibroBiologics达成ATM发行协议 拟发售最高615万美元普通股
美股速递
·
05/02
FibroBiologics与United Fire & Casualty签订租约终止协议,生效日期为2026年4月3日
美股速递
·
04/10
FibroBiologics宣布成功生产Cywc628药物产品,为即将开展的糖尿病足溃疡临床试验提供支持
美股速递
·
04/01
FibroBiologics宣布实施合股计划,旨在重新符合纳斯达克最低买入价规定
美股速递
·
03/26
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/FBLG/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FBLG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","market":"US","secType":"STK","nameCN":"FibroBiologics","latestPrice":1.76,"timestamp":1788984000000,"preClose":1.71,"halted":0,"volume":138311,"hourTrading":{"tag":"盘前","latestPrice":1.8,"preClose":1.76,"latestTime":"07:48 EDT","volume":19,"amount":33.6399997,"timestamp":1789040904565,"change":0.04,"changeRate":0.022727,"amplitude":0.022727},"delay":0,"changeRate":0.02923976608187137,"floatShares":5843116,"shares":6658193,"eps":-4.765638,"marketStatus":"盘前交易","change":0.05,"latestTime":"09-10 08:09:25 EDT","open":1.73,"high":1.8,"low":1.62,"amount":239358.25038,"amplitude":0.105263,"askPrice":1.92,"askSize":12,"bidPrice":1.49,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.765638,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"listingDate":1706677200000,"exchange":"NASDAQ","adjPreClose":1.76,"preHourTrading":{"tag":"盘前","latestPrice":1.8,"preClose":1.76,"latestTime":"07:48 EDT","volume":19,"amount":33.6399997,"timestamp":1789040904565,"change":0.04,"changeRate":0.022727,"amplitude":0.022727},"postHourTrading":{"tag":"盘后","latestPrice":1.67,"preClose":1.76,"latestTime":"19:04 EDT","volume":5718,"amount":10319.748,"timestamp":1788995047075,"change":-0.09,"changeRate":-0.051136,"amplitude":0.135},"volumeRatio":0.23625806553404355},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","floatShares":5843116,"roa":"-95.77%","roe":"-660.08%","lyrEps":-8.3501,"volumeRatio":0.23625806553404355,"shares":6658193,"dividePrice":0,"high":1.8,"amplitude":0.105263,"preClose":1.71,"low":1.62,"week52Low":0.62005,"pbRate":"2.53","week52High":12.4,"institutionHeld":0,"latestPrice":1.76,"committee":0.785714,"eps":-4.765638,"divideRate":0,"volume":138311,"delay":0,"ttmEps":-4.765638,"open":1.73,"prevYearClose":4.498,"prevWeekClose":1.81,"prevMonthClose":1.72,"prevQuarterClose":0.9477,"fiveDayClose":2.11,"twentyDayClose":1.03,"sixtyDayClose":0.931},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBLG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-31","symbol":"FBLG","fiscalQuarterEnding":"2026/06","expectedEps":-0.93,"name":null,"time":"盘后","type":"earning","dateTimestamp":1785470400000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2026-04-30","symbol":"FBLG","fiscalQuarterEnding":"2026/03","expectedEps":-1.26,"name":null,"time":"盘后","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"post","actualEps":-1.33},{"market":"US","date":"2026-03-30","symbol":"FBLG","defaultRemindTime":1774877400000,"type":"split","dateTimestamp":1774843200000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2026-02-24","symbol":"FBLG","fiscalQuarterEnding":"2025/12","expectedEps":-0.09,"name":null,"time":"盘后","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2025-10-31","symbol":"FBLG","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"盘后","type":"earning","dateTimestamp":1761883200000,"reportTimeType":"post","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBLG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBLG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1777953600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FBLG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FBLG","date":"2026-09-08","current":-0.36931,"percent":0.830428,"low":-68.573467,"twenty":-5.878908,"median":-2.853034,"eighty":-0.861599,"high":-0.181252,"avg":-5.796934,"sd":9.532784,"marketCap":12051329},"quantilePoints":[{"date":"2024-02-02","current":-68.573467,"twenty":-68.573467,"median":-68.573467,"eighty":-68.573467,"marketCap":568611190},{"date":"2024-02-09","current":-30.642544,"twenty":-58.777258,"median":-48.452053,"eighty":-34.01244,"marketCap":254087971},{"date":"2024-02-16","current":-50.313332,"twenty":-58.777258,"median":-50.313332,"eighty":-30.642544,"marketCap":417198153},{"date":"2024-02-23","current":-47.413654,"twenty":-56.896385,"median":-48.5892,"eighty":-33.338461,"marketCap":393154022},{"date":"2024-03-01","current":-25.741365,"twenty":-54.984165,"median":-48.491237,"eighty":-33.338461,"marketCap":424346408},{"date":"2024-03-08","current":-19.47356,"twenty":-53.244359,"median":-47.492024,"eighty":-25.717713,"marketCap":321021631},{"date":"2024-03-15","current":-20.892685,"twenty":-51.363486,"median":-37.245189,"eighty":-20.955758,"marketCap":344415920},{"date":"2024-03-22","current":-23.849198,"twenty":-50.446561,"median":-28.99678,"eighty":-20.813845,"marketCap":393154022},{"date":"2024-03-28","current":-23.159345,"twenty":-50.219289,"median":-25.741365,"eighty":-20.93999,"marketCap":381781799},{"date":"2024-04-05","current":-22.469492,"twenty":-49.216157,"median":-24.637601,"eighty":-21.160743,"marketCap":370409575},{"date":"2024-04-12","current":-22.311811,"twenty":-48.471645,"median":-23.652097,"eighty":-21.298713,"marketCap":367810209},{"date":"2024-04-19","current":-21.700799,"twenty":-48.064123,"median":-23.20862,"eighty":-21.030656,"marketCap":357737668},{"date":"2024-04-26","current":-23.021374,"twenty":-47.63309,"median":-22.804563,"eighty":-21.030656,"marketCap":379507354},{"date":"2024-05-03","current":-13.245174,"twenty":-47.445002,"median":-22.479347,"eighty":-20.675875,"marketCap":218346696},{"date":"2024-05-10","current":-17.22661,"twenty":-43.252224,"median":-22.05558,"eighty":-19.871704,"marketCap":283980674},{"date":"2024-05-17","current":-17.017594,"twenty":-36.598639,"median":-21.769784,"eighty":-19.221271,"marketCap":383406402},{"date":"2024-05-24","current":-16.310932,"twenty":-31.990502,"median":-21.661379,"eighty":-18.255477,"marketCap":367485289},{"date":"2024-05-31","current":-17.767522,"twenty":-29.984238,"median":-21.543118,"eighty":-17.827098,"marketCap":400302277},{"date":"2024-06-07","current":-14.972667,"twenty":-28.19741,"median":-21.306597,"eighty":-17.252609,"marketCap":337334178},{"date":"2024-06-14","current":-10.427133,"twenty":-26.746956,"median":-21.178482,"eighty":-16.659936,"marketCap":234923317},{"date":"2024-06-21","current":-7.769521,"twenty":-25.741365,"median":-20.932105,"eighty":-16.368618,"marketCap":175047318},{"date":"2024-06-28","current":-6.767471,"twenty":-25.694061,"median":-20.88283,"eighty":-16.302279,"marketCap":152471122},{"date":"2024-07-05","current":-6.143005,"twenty":-25.43783,"median":-20.64631,"eighty":-15.81876,"marketCap":138401898},{"date":"2024-07-12","current":-7.689204,"twenty":-24.673079,"median":-20.183123,"eighty":-14.136173,"marketCap":173237756},{"date":"2024-07-15","current":-7.514809,"twenty":-24.649427,"median":-20.094427,"eighty":-13.517924,"marketCap":169308652},{"date":"2024-08-02","current":-7.974576,"twenty":-24.625775,"median":-20.005732,"eighty":-13.175194,"marketCap":179667198},{"date":"2024-08-09","current":-4.080921,"twenty":-24.140907,"median":-19.700225,"eighty":-10.836667,"marketCap":79459622},{"date":"2024-08-16","current":-2.166861,"twenty":-23.730937,"median":-18.842837,"eighty":-9.439605,"marketCap":42190950},{"date":"2024-08-23","current":-2.546062,"twenty":-23.640271,"median":-18.638558,"eighty":-7.79743,"marketCap":49574366},{"date":"2024-08-30","current":-2.915474,"twenty":-23.407692,"median":-18.172694,"eighty":-7.552859,"marketCap":56767191},{"date":"2024-09-06","current":-3.368187,"twenty":-23.218475,"median":-17.767522,"eighty":-6.924314,"marketCap":65581972},{"date":"2024-09-13","current":-5.722296,"twenty":-23.104157,"median":-17.428613,"eighty":-6.143005,"marketCap":111418835},{"date":"2024-09-20","current":-5.722296,"twenty":-22.93465,"median":-17.22661,"eighty":-5.90745,"marketCap":111418835},{"date":"2024-09-27","current":-5.686079,"twenty":-22.765143,"median":-16.563311,"eighty":-5.873037,"marketCap":110713652},{"date":"2024-10-04","current":-4.798761,"twenty":-22.619289,"median":-16.368618,"eighty":-5.722296,"marketCap":93436681},{"date":"2024-10-11","current":-4.20118,"twenty":-22.481318,"median":-16.080185,"eighty":-5.265962,"marketCap":81801170},{"date":"2024-10-18","current":-6.012033,"twenty":-22.40642,"median":-15.807485,"eighty":-5.066768,"marketCap":117060295},{"date":"2024-10-25","current":-5.215258,"twenty":-22.209319,"median":-15.237992,"eighty":-5.131958,"marketCap":101546280},{"date":"2024-10-31","current":-5.342017,"twenty":-22.020102,"median":-13.586112,"eighty":-5.110228,"marketCap":104014418},{"date":"2024-11-08","current":-6.464746,"twenty":-21.866364,"median":-12.649071,"eighty":-5.128337,"marketCap":125875076},{"date":"2024-11-15","current":-5.477931,"twenty":-21.799349,"median":-10.768411,"eighty":-5.146445,"marketCap":97392141},{"date":"2024-11-22","current":-4.698155,"twenty":-21.716567,"median":-9.773622,"eighty":-5.018763,"marketCap":83528491},{"date":"2024-11-29","current":-5.107537,"twenty":-21.700799,"median":-9.003931,"eighty":-5.016064,"marketCap":90806907},{"date":"2024-12-06","current":-4.639671,"twenty":-21.661379,"median":-7.895306,"eighty":-4.997955,"marketCap":82488717},{"date":"2024-12-13","current":-4.425233,"twenty":-21.562828,"median":-7.720912,"eighty":-4.979847,"marketCap":78676213},{"date":"2024-12-20","current":-3.957367,"twenty":-21.543118,"median":-7.546517,"eighty":-4.853087,"marketCap":70358023},{"date":"2024-12-27","current":-4.50321,"twenty":-21.511582,"median":-7.203145,"eighty":-4.778145,"marketCap":80062578},{"date":"2025-01-03","current":-3.869642,"twenty":-21.385437,"median":-6.905845,"eighty":-4.698155,"marketCap":68798363},{"date":"2025-01-10","current":-4.065278,"twenty":-21.306597,"median":-6.609614,"eighty":-4.652603,"marketCap":72276579},{"date":"2025-01-17","current":-3.769263,"twenty":-21.298713,"median":-6.286711,"eighty":-4.50321,"marketCap":67013721},{"date":"2025-01-24","current":-3.157497,"twenty":-21.243525,"median":-6.193118,"eighty":-4.433031,"marketCap":56137148},{"date":"2025-01-31","current":-3.295638,"twenty":-21.050366,"median":-6.140899,"eighty":-4.36675,"marketCap":58593149},{"date":"2025-02-07","current":-3.157497,"twenty":-20.955758,"median":-6.004281,"eighty":-4.203103,"marketCap":56137148},{"date":"2025-02-14","current":-2.545732,"twenty":-20.888743,"median":-5.948653,"eighty":-4.068407,"marketCap":45260576},{"date":"2025-02-21","current":-2.447061,"twenty":-20.872975,"median":-5.908467,"eighty":-3.946872,"marketCap":43506290},{"date":"2025-02-28","current":-2.348389,"twenty":-20.794135,"median":-5.885273,"eighty":-3.784683,"marketCap":41752004},{"date":"2025-03-07","current":-2.210248,"twenty":-20.498484,"median":-5.867165,"eighty":-3.670591,"marketCap":39296004},{"date":"2025-03-14","current":-2.109947,"twenty":-20.183123,"median":-5.776622,"eighty":-3.453513,"marketCap":37512750},{"date":"2025-03-21","current":-2.151728,"twenty":-20.183123,"median":-5.722296,"eighty":-3.368187,"marketCap":38255577},{"date":"2025-03-28","current":-2.130838,"twenty":-20.005732,"median":-5.595537,"eighty":-3.295638,"marketCap":37884163},{"date":"2025-04-04","current":-2.958372,"twenty":-19.926892,"median":-5.518575,"eighty":-3.165965,"marketCap":33018387},{"date":"2025-04-11","current":-2.748074,"twenty":-19.788921,"median":-5.342017,"eighty":-3.105834,"marketCap":30671251},{"date":"2025-04-17","current":-3.685286,"twenty":-19.647008,"median":-5.282987,"eighty":-3.104326,"marketCap":41131477},{"date":"2025-04-25","current":-4.361485,"twenty":-19.501154,"median":-5.215258,"eighty":-3.131377,"marketCap":48678537},{"date":"2025-05-02","current":-3.496805,"twenty":-18.968982,"median":-5.142823,"eighty":-3.15355,"marketCap":39027837},{"date":"2025-05-09","current":-2.900977,"twenty":-18.732461,"median":-5.107537,"eighty":-3.105179,"marketCap":32377800},{"date":"2025-05-16","current":-5.090366,"twenty":-18.693381,"median":-5.090366,"eighty":-3.095239,"marketCap":39027837},{"date":"2025-05-23","current":-4.291877,"twenty":-18.607387,"median":-5.049055,"eighty":-3.101704,"marketCap":32905823},{"date":"2025-05-30","current":-3.742916,"twenty":-18.421041,"median":-5.00701,"eighty":-3.104523,"marketCap":28696939},{"date":"2025-06-06","current":-4.262932,"twenty":-18.227882,"median":-4.979847,"eighty":-3.124991,"marketCap":32683900},{"date":"2025-06-13","current":-4.354259,"twenty":-18.018955,"median":-4.934576,"eighty":-3.149603,"marketCap":33384106},{"date":"2025-06-20","current":-3.674878,"twenty":-17.856887,"median":-4.868731,"eighty":-3.157497,"marketCap":28175292},{"date":"2025-06-27","current":-3.644169,"twenty":-17.748258,"median":-4.815121,"eighty":-3.160884,"marketCap":27939844},{"date":"2025-07-03","current":-3.132347,"twenty":-17.688614,"median":-4.795627,"eighty":-3.157497,"marketCap":24015708},{"date":"2025-07-11","current":-3.321721,"twenty":-17.510817,"median":-4.711647,"eighty":-3.13343,"marketCap":25467638},{"date":"2025-07-18","current":-3.531568,"twenty":-17.278608,"median":-4.698155,"eighty":-3.14171,"marketCap":27076534},{"date":"2025-07-25","current":-3.36062,"twenty":-17.22661,"median":-4.675331,"eighty":-3.157497,"marketCap":25765873},{"date":"2025-08-01","current":-3.260303,"twenty":-17.184807,"median":-4.665775,"eighty":-3.157497,"marketCap":24996742},{"date":"2025-08-08","current":-1.692292,"twenty":-16.92818,"median":-4.639671,"eighty":-3.111465,"marketCap":22377179},{"date":"2025-08-15","current":-1.862725,"twenty":-16.567638,"median":-4.558872,"eighty":-3.098103,"marketCap":24630815},{"date":"2025-08-22","current":-1.865576,"twenty":-16.533025,"median":-4.524553,"eighty":-3.074912,"marketCap":24668515},{"date":"2025-08-29","current":-1.964732,"twenty":-16.426305,"median":-4.50321,"eighty":-3.015849,"marketCap":25979645},{"date":"2025-09-05","current":-1.881416,"twenty":-16.368618,"median":-4.425233,"eighty":-2.962429,"marketCap":24877961},{"date":"2025-09-12","current":-1.789547,"twenty":-16.310932,"median":-4.376497,"eighty":-2.933582,"marketCap":23663176},{"date":"2025-09-19","current":-1.694826,"twenty":-16.29651,"median":-4.361485,"eighty":-2.897365,"marketCap":22410690},{"date":"2025-09-26","current":-1.709716,"twenty":-15.863859,"median":-4.348021,"eighty":-2.853034,"marketCap":22607569},{"date":"2025-10-03","current":-1.710666,"twenty":-15.863859,"median":-4.327761,"eighty":-2.748074,"marketCap":22620136},{"date":"2025-10-10","current":-1.544034,"twenty":-15.807485,"median":-4.261494,"eighty":-2.486529,"marketCap":20416767},{"date":"2025-10-17","current":-1.298839,"twenty":-15.630094,"median":-4.210794,"eighty":-2.348389,"marketCap":17174548},{"date":"2025-10-24","current":-1.301056,"twenty":-15.503317,"median":-4.186877,"eighty":-2.318853,"marketCap":17203870},{"date":"2025-10-31","current":-1.257339,"twenty":-14.972667,"median":-4.132817,"eighty":-2.297962,"marketCap":16625800},{"date":"2025-11-07","current":-0.932278,"twenty":-13.927049,"median":-4.072247,"eighty":-2.249717,"marketCap":17248077},{"date":"2025-11-14","current":-0.933669,"twenty":-13.245174,"median":-4.04235,"eighty":-2.172619,"marketCap":17273805},{"date":"2025-11-21","current":-0.902797,"twenty":-13.070223,"median":-4.004863,"eighty":-2.130838,"marketCap":16702642},{"date":"2025-11-28","current":-0.907742,"twenty":-12.733301,"median":-3.95212,"eighty":-2.105769,"marketCap":16794130},{"date":"2025-12-05","current":-0.861361,"twenty":-11.417566,"median":-3.918378,"eighty":-2.038689,"marketCap":15936036},{"date":"2025-12-12","current":-1.151904,"twenty":-11.10969,"median":-3.880347,"eighty":-1.962831,"marketCap":21311383},{"date":"2025-12-19","current":-0.864342,"twenty":-10.563644,"median":-3.855551,"eighty":-1.925449,"marketCap":15991199},{"date":"2025-12-26","current":-0.781519,"twenty":-10.366139,"median":-3.817676,"eighty":-1.905048,"marketCap":14458888},{"date":"2026-01-02","current":-0.80862,"twenty":-10.104734,"median":-3.784683,"eighty":-1.867667,"marketCap":14960285},{"date":"2026-01-09","current":-1.186504,"twenty":-9.756195,"median":-3.726488,"eighty":-1.863485,"marketCap":21951508},{"date":"2026-01-16","current":-1.21347,"twenty":-9.439605,"median":-3.689721,"eighty":-1.817994,"marketCap":22450406},{"date":"2026-01-23","current":-1.222459,"twenty":-8.832939,"median":-3.685286,"eighty":-1.804182,"marketCap":22616705},{"date":"2026-01-30","current":-1.226773,"twenty":-8.114091,"median":-3.670176,"eighty":-1.745069,"marketCap":22696529},{"date":"2026-02-06","current":-0.81653,"twenty":-7.942868,"median":-3.64061,"eighty":-1.71998,"marketCap":15106628},{"date":"2026-02-13","current":-0.884485,"twenty":-7.806733,"median":-3.5628,"eighty":-1.705851,"marketCap":16363851},{"date":"2026-02-20","current":-0.903181,"twenty":-7.769521,"median":-3.544415,"eighty":-1.692292,"marketCap":16709754},{"date":"2026-02-27","current":-1.025558,"twenty":-7.720912,"median":-3.492982,"eighty":-1.665999,"marketCap":19122546},{"date":"2026-03-06","current":-1.519667,"twenty":-7.689204,"median":-3.463009,"eighty":-1.553538,"marketCap":28335707},{"date":"2026-03-13","current":-1.232917,"twenty":-7.578225,"median":-3.43637,"eighty":-1.519667,"marketCap":22988964},{"date":"2026-03-20","current":-0.927678,"twenty":-7.514809,"median":-3.414459,"eighty":-1.43094,"marketCap":17297489},{"date":"2026-03-27","current":-0.797535,"twenty":-7.246713,"median":-3.39431,"eighty":-1.385333,"marketCap":14870838},{"date":"2026-04-02","current":-0.241073,"twenty":-7.177005,"median":-3.378022,"eighty":-1.359957,"marketCap":4495048},{"date":"2026-04-10","current":-0.336129,"twenty":-7.067291,"median":-3.359084,"eighty":-1.328997,"marketCap":6267453},{"date":"2026-04-17","current":-0.370229,"twenty":-6.822821,"median":-3.321721,"eighty":-1.299599,"marketCap":6903282},{"date":"2026-04-24","current":-0.367793,"twenty":-6.742593,"median":-3.30892,"eighty":-1.267223,"marketCap":6857865},{"date":"2026-05-01","current":-0.368753,"twenty":-6.533559,"median":-3.275657,"eighty":-1.232416,"marketCap":6875767},{"date":"2026-05-08","current":-0.345774,"twenty":-6.468368,"median":-3.258236,"eighty":-1.221308,"marketCap":6459054},{"date":"2026-05-15","current":-0.312154,"twenty":-6.322318,"median":-3.235952,"eighty":-1.201893,"marketCap":5831040},{"date":"2026-05-22","current":-0.303483,"twenty":-6.255297,"median":-3.19076,"eighty":-1.171044,"marketCap":5669067},{"date":"2026-05-29","current":-0.326606,"twenty":-6.214848,"median":-3.171598,"eighty":-1.119059,"marketCap":6100996},{"date":"2026-06-05","current":-0.309264,"twenty":-6.16305,"median":-3.157497,"eighty":-1.023143,"marketCap":5777049},{"date":"2026-06-12","current":-0.278626,"twenty":-6.143005,"median":-3.135055,"eighty":-0.995266,"marketCap":5204743},{"date":"2026-06-18","current":-0.231225,"twenty":-6.14132,"median":-3.119296,"eighty":-0.966672,"marketCap":4319289},{"date":"2026-06-26","current":-0.211918,"twenty":-6.088089,"median":-3.102557,"eighty":-0.949468,"marketCap":3958628},{"date":"2026-07-02","current":-0.261949,"twenty":-6.010483,"median":-3.098055,"eighty":-0.939027,"marketCap":4893215},{"date":"2026-07-10","current":-0.248856,"twenty":-6.001989,"median":-3.08079,"eighty":-0.932373,"marketCap":4648635},{"date":"2026-07-17","current":-0.242729,"twenty":-5.989422,"median":-3.058826,"eighty":-0.919078,"marketCap":4534174},{"date":"2026-07-24","current":-0.212583,"twenty":-5.964951,"median":-3.025992,"eighty":-0.912766,"marketCap":3971046},{"date":"2026-07-31","current":-0.207872,"twenty":-5.92149,"median":-2.981001,"eighty":-0.907742,"marketCap":3883041},{"date":"2026-08-07","current":-0.374406,"twenty":-5.913552,"median":-2.958372,"eighty":-0.904979,"marketCap":6791356},{"date":"2026-08-14","current":-0.422125,"twenty":-5.903382,"median":-2.937355,"eighty":-0.902462,"marketCap":7656921},{"date":"2026-08-21","current":-0.473514,"twenty":-5.885273,"median":-2.907657,"eighty":-0.890492,"marketCap":8589068},{"date":"2026-08-28","current":-0.546927,"twenty":-5.885273,"median":-2.888543,"eighty":-0.871962,"marketCap":9920707},{"date":"2026-09-04","current":-0.646034,"twenty":-5.881844,"median":-2.853034,"eighty":-0.862552,"marketCap":11718419},{"date":"2026-09-08","current":-0.664388,"twenty":-5.878908,"median":-2.853034,"eighty":-0.861599,"marketCap":12051329}],"updateTime":1789024273146},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBLG\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1140980227","title":"FibroBiologics宣布获得美国新专利:利用成纤维细胞条件培养基治疗椎间盘退行性疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1140980227","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140980227?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 20:31","pubTimestamp":1788265870,"startTime":"0","endTime":"0","summary":"FibroBiologics今日宣告,其一项针对椎间盘退行性疾病治疗的新美国专利已正式获批。此项专利聚焦于成纤维细胞条件培养基的应用,为该疾病的治疗开辟了全新路径。这标志着公司在再生医学领域的持续深耕又迈出了坚实一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199334671","title":"Fibrobiologics发布第三批Cywc628药物产品,用于1/2期糖尿病足溃疡临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1199334671","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199334671?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 20:34","pubTimestamp":1787834050,"startTime":"0","endTime":"0","summary":"Fibrobiologics公司宣布,已成功生产并发布第三批Cywc628药物产品,该产品将用于其正在进行的1/2期糖尿病足溃疡临床试验。这一里程碑式的进展,标志着该公司在推进这一潜在治疗方案的道路上又迈出了坚实的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113784192","title":"Fibrobiologics宣布:大麻二酚辅助治疗椎间盘退行性疾病的澳大利亚专利已获授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1113784192","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113784192?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 20:34","pubTimestamp":1787229259,"startTime":"0","endTime":"0","summary":"Fibrobiologics今日宣告,其针对大麻二酚作为辅助疗法用于治疗椎间盘退行性疾病的相关专利,已获得澳大利亚方面的正式受理与批准。Fibrobiologics此番将目光投向大麻二酚这一非精神活性成分,试图探索其在缓解炎症、调节疼痛通路等方面的潜在临床价值,并以此为基础构建新的治疗策略。据悉,该项专利的获准不仅为Fibrobiologics在澳大利亚市场的后续研发和商业化运作铺平了道路,也进一步强化了其在该细分领域的技术壁垒。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658137399","title":"FibroBiologics 因一项与胰岛素分泌细胞移植技术相关的专利而获益","url":"https://stock-news.laohu8.com/highlight/detail?id=2658137399","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658137399?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 21:18","pubTimestamp":1786454330,"startTime":"0","endTime":"0","summary":"BUZZ-FibroBiologics 因一项与胰岛素分泌细胞移植技术相关的专利而获益8月11日-** 生物技术公司 FibroBiologics的股价在盘前交易中上涨 2%,至 1.00 美元** 该公司表示,美国专利局已授予一项专利,该专利涉及利用成纤维细胞改善1型糖尿病胰岛细胞移植的技术。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4T4480YQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172853300","title":"FibroBiologics获美国专利:成纤维细胞可增强移植胰岛细胞存活与功能","url":"https://stock-news.laohu8.com/highlight/detail?id=1172853300","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172853300?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 20:32","pubTimestamp":1786451534,"startTime":"0","endTime":"0","summary":"FibroBiologics(FBLG)近日宣布,已获得一项美国专利授权。该专利覆盖了利用成纤维细胞来增强移植后胰岛素生产胰岛细胞的存活率与功能。这一技术突破,有望为糖尿病细胞疗法带来新的助力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657249513","title":"FibroBiologics 2026年第二季度财报:净亏损410万美元,CYWC628进入临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2657249513","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657249513?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 14:13","pubTimestamp":1785910401,"startTime":"0","endTime":"0","summary":"FibroBiologics(FBLG)2026年第二季度净亏损约410万美元,研发费用降至170万美元,期末现金约350万美元;CYWC628已启动患者给药,预计下半年公布中期结果。","market":"us","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock7.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock7.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/earnings/262075599-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","PSET","SQMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181092968","title":"FibroBiologics发布2026年第二季度财报:主导伤口护理候选药物临床试验稳步推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1181092968","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181092968?lang=zh_cn&edition=fundamental","pubTime":"2026-08-01 05:35","pubTimestamp":1785533709,"startTime":"0","endTime":"0","summary":"FibroBiologics(股票代码:FBLG)近日披露了其2026年第二季度的财务业绩。与此同时,该公司在评估其核心伤口护理候选药物的临床试验方面,也取得了显著进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157352361","title":"FibroBiologics提交SEC文件:注册出售股东至多1253万股普通股转售","url":"https://stock-news.laohu8.com/highlight/detail?id=1157352361","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157352361?lang=zh_cn&edition=fundamental","pubTime":"2026-07-10 18:07","pubTimestamp":1783678031,"startTime":"0","endTime":"0","summary":"FibroBiologics已向美国证券交易委员会提交文件,为其部分出售股东注册了高达1253万股普通股的转售资格。此举意味着,持有这些已注册股份的股东未来可在公开市场出售这些股票,而公司本身不会从此次转售中获得任何收益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128222368","title":"FibroBiologics完成第三批Cywc628药物生产,用于糖尿病足溃疡1/2期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1128222368","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128222368?lang=zh_cn&edition=fundamental","pubTime":"2026-07-07 20:35","pubTimestamp":1783427707,"startTime":"0","endTime":"0","summary":"FibroBiologics宣布,已完成用于糖尿病足溃疡1/2期临床试验的第三批Cywc628药物产品的生产工作。该进展标志着公司针对这一适应症的临床开发计划取得了关键一步,为后续的试验推进提供了必要的材料保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150619750","title":"FibroBiologics宣布完成最高900万美元按市价定价的私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1150619750","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150619750?lang=zh_cn&edition=fundamental","pubTime":"2026-06-30 04:02","pubTimestamp":1782763335,"startTime":"0","endTime":"0","summary":"FibroBiologics公司宣布,其依据纳斯达克规则按市价定价的私募配售已正式完成,此次融资规模最高可达900万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167139626","title":"FibroBiologics获美国专利授权通知,覆盖用于伤口愈合的局部成纤维细胞球体疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1167139626","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167139626?lang=zh_cn&edition=fundamental","pubTime":"2026-06-22 20:32","pubTimestamp":1782131575,"startTime":"0","endTime":"0","summary":"FibroBiologics公司已收到关于一项美国专利的授权通知,该专利涵盖了用于伤口愈合的局部成纤维细胞球体疗法。这一进展标志着该公司在再生医学领域的技术开发取得了重要里程碑。成纤维细胞球体疗法是一种创新的治疗方式,旨在通过局部应用促进组织修复和伤口愈合。专利的授权将为该疗法的进一步开发和商业化提供关键的知识产权保护。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115715028","title":"FibroBiologics推进针对糖尿病足溃疡的Ciwc628药物1/2期临床试验患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1115715028","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115715028?lang=zh_cn&edition=fundamental","pubTime":"2026-06-16 20:31","pubTimestamp":1781613092,"startTime":"0","endTime":"0","summary":"FibroBiologics公司宣布,其用于治疗糖尿病足溃疡的研究性药物Ciwc628的1/2期临床试验已取得进展,进入患者给药阶段。这一步骤标志着该疗法在临床开发路径上的重要推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156476620","title":"FibroBiologics宣布首批患者接受Cywc628治疗糖尿病足溃疡的1/2期临床试验给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1156476620","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156476620?lang=zh_cn&edition=fundamental","pubTime":"2026-06-03 19:02","pubTimestamp":1780484567,"startTime":"0","endTime":"0","summary":"FibroBiologics宣布,其用于治疗糖尿病足溃疡的在研药物Cywc628,已在1/2期临床试验中为首批患者完成给药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119164458","title":"新闻稿:FibroBiologics 在皮肤研究学会2026年会上公布临床前数据,展示其银屑病疗法持久的免疫调节作用","url":"https://stock-news.laohu8.com/highlight/detail?id=1119164458","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119164458?lang=zh_cn&edition=fundamental","pubTime":"2026-05-22 20:31","pubTimestamp":1779453094,"startTime":"0","endTime":"0","summary":"FibroBiologics 是一家拥有超过270项已授权和申请中专利的临床阶段生物技术公司,专注于利用成纤维细胞及其衍生材料开发慢性疾病的治疗方法和潜在治愈方案。该公司今日公布了其针对银屑病的CYPS317项目在皮肤研究学会2026年会上展示的临床前数据。该年会于2026年5月13日至15日在伊利诺伊州芝加哥举行。这些前瞻性声明基于FibroBiologics管理层当前的预期、估计、预测和信念,以及对未来事件的一系列假设。FibroBiologics不保证其能够实现预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131452413","title":"FibroBiologics启动1/2期临床试验 评估CYWc628对糖尿病足溃疡患者的安全性、耐受性及疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1131452413","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131452413?lang=zh_cn&edition=fundamental","pubTime":"2026-05-04 20:31","pubTimestamp":1777897876,"startTime":"0","endTime":"0","summary":"生物技术公司FibroBiologics宣布,将开展一项针对糖尿病足溃疡患者的1/2期临床研究。该试验旨在系统评估候选药物CYWc628在患者群体中的安全性表现、耐受性水平以及潜在治疗效果。\n这项临床研究的推进,标志着FibroBiologics在细胞疗法领域取得了新的阶段性进展。通过严谨的临床试验设计,公司期望为糖尿病足溃疡这一难治性疾病的治疗提供新的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170332450","title":"FibroBiologics宣布Cywc628药物产品完成生产 将用于糖尿病足溃疡1/2期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1170332450","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170332450?lang=zh_cn&edition=fundamental","pubTime":"2026-05-04 20:30","pubTimestamp":1777897838,"startTime":"0","endTime":"0","summary":"生物技术公司FibroBiologics正式宣布,其针对糖尿病足溃疡治疗的核心候选药物Cywc628已完成生产放行流程。该批药物将立即投入即将启动的1/2期临床试验阶段,标志着公司在纤维细胞疗法领域取得关键进展。\n此次药物放行严格遵循药品生产质量管理规范,确保临床试验用药的安全性与稳定性。糖尿病足溃疡作为糖尿病最常见的严重并发症之一,目前临床治疗手段有限,Cywc628的推进将为患者提供潜在的新型治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156447376","title":"FibroBiologics达成ATM发行协议 拟发售最高615万美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1156447376","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156447376?lang=zh_cn&edition=fundamental","pubTime":"2026-05-02 04:04","pubTimestamp":1777665867,"startTime":"0","endTime":"0","summary":"再生医学公司FibroBiologics(股票代码:FBLG)近日向美国证券交易委员会(SEC)提交文件,宣布已签订一项市场发行(ATM)协议。根据该协议,公司获权通过承销商发售价值最高达615万美元的普通股。\nATM发行机制允许上市公司根据市场情况灵活择机发售新股,此举将为FibroBiologics提供额外的运营资金。该公司专注于利用成纤维细胞技术开发慢性疾病创新疗法,此次融资将加速其细胞疗法管线的临床推进。\n此次发行具体条款将取决于市场条件、股价波动及公司资金需求等因素。通过这种股权融资方式,FibroBiologics有望在保持资金灵活性的同时,为长期研发投入提供支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125810558","title":"FibroBiologics与United Fire & Casualty签订租约终止协议,生效日期为2026年4月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=1125810558","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125810558?lang=zh_cn&edition=fundamental","pubTime":"2026-04-10 04:22","pubTimestamp":1775766154,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会(SEC)提交的文件,FibroBiologics公司已与United Fire & Casualty达成一项租约终止协议,该协议将于2026年4月3日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128604799","title":"FibroBiologics宣布成功生产Cywc628药物产品,为即将开展的糖尿病足溃疡临床试验提供支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1128604799","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128604799?lang=zh_cn&edition=fundamental","pubTime":"2026-04-01 04:16","pubTimestamp":1774988194,"startTime":"0","endTime":"0","summary":"FibroBiologics公司近日宣布,已成功完成Cywc628药物产品的生产工作,该产品将用于支持即将启动的糖尿病足溃疡临床试验。这一进展标志着公司在细胞纤维化治疗领域迈出重要一步,也为后续临床研究奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150891053","title":"FibroBiologics宣布实施合股计划,旨在重新符合纳斯达克最低买入价规定","url":"https://stock-news.laohu8.com/highlight/detail?id=1150891053","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150891053?lang=zh_cn&edition=fundamental","pubTime":"2026-03-26 04:31","pubTimestamp":1774470675,"startTime":"0","endTime":"0","summary":"FibroBiologics(股票代码:FBLG)近日公布一项重要举措,公司将进行反向股票分割(reverse stock split),以恢复对纳斯达克交易所最低买入价要求的合规状态。此举旨在通过调整流通股数量,提升每股市场交易价格,从而满足交易所持续上市标准中关于股价的规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}